Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Actoplus met XR

Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Terminated Packaging defect Takeda Development Center Americas, Inc. D-0026-2019
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6675-8 D-1210-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6625-8 D-1209-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6650-8 D-1208-2018

Recalls by year